NCT01229137

Brief Summary

Assessment of sensor parameter in patients with heart failure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
71

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2011

Geographic Reach
1 country

14 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 27, 2010

Completed
7 months until next milestone

Study Start

First participant enrolled

June 1, 2011

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
Last Updated

September 12, 2012

Status Verified

September 1, 2012

Enrollment Period

1.2 years

First QC Date

October 25, 2010

Last Update Submit

September 10, 2012

Conditions

Study Arms (3)

Right Ventricular Cohort

Right Ventricle wtih SRD-1 conversion

Device: SRD-1 conversion

Left Ventricular Cohort

Left Ventricle with SRD-1 conversion

Device: SRD-1 conversion

Right Atrium Cohart

Right atrium cohort with SRD-1 conversion

Device: SRD-1 conversion

Interventions

Left Ventricular CohortRight Atrium CohartRight Ventricular Cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Heart failure patients with an implanted CRT-D

You may qualify if:

  • COGNIS CRT-D model N119 or N120, functional bipolar leads: RA, RV, and LV lead all implanted for a minimum of 30 days
  • Prescribed to optimal pharmacologic therapy for heart failure for at least 30 days prior to enrollment
  • Age 18 or above, or of legal age to give informed consent specific to state and national law

You may not qualify if:

  • Documented HF decompensation, as defined by a hospitalization or greater than a doubling of baseline diuretic dose due to worsening HF, within the last 3 months
  • Patients who are pacemaker dependent
  • Creatinine ≥ 2.5 mg/dL test within the last 3 months
  • Requires assistance walking, for example a cane or walker
  • Have an atrial tachyarrhythmia that is permanent or persistent
  • Have moderate to severe chronic pulmonary disease as defined by FEV1 \< 55% predicted
  • Documented life expectancy of less than 6 months
  • Patients at an unreasonable risk of not being able to reach the investigational center in case of an emergency, per physician discretion
  • Enrolled in any concurrent study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (14)

Cardiovascular Associates of Northeast Arkansas

Jonesboro, Arkansas, 72401, United States

Location

Regional Cardiology Consultants

Sacremento, California, 95819, United States

Location

Danbury Hospital

Danbury, Connecticut, 06810, United States

Location

Heart and Vascular Institute of Florida

Clearwater, Florida, 33756, United States

Location

Genesis Medical Center

Davenport, Iowa, 52803, United States

Location

University of Massachusetts Memorial Medical Center

Worcester, Massachusetts, 01655, United States

Location

St. John's Hospital and Medical Center

Detroit, Michigan, 48236, United States

Location

United Heart and Vascular Clinic

Saint Paul, Minnesota, 55102, United States

Location

Hackensack University Medical Center

Hackensack, New Jersey, 07601, United States

Location

Cardiovascular Research Institure, LLC

Canton, Ohio, 44708, United States

Location

Texas Cardiac Arrhythmia Research

Austin, Texas, 78705, United States

Location

Tyler Cardiovascular Associates

Tyler, Texas, 75701, United States

Location

Thomas Bunch

Murray, Utah, 84157, United States

Location

University of Virginia Medical Center

Charlottesville, Virginia, 22908, United States

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Alan Bank, M.D.

    United Heart and Vascular Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 25, 2010

First Posted

October 27, 2010

Study Start

June 1, 2011

Primary Completion

August 1, 2012

Study Completion

August 1, 2012

Last Updated

September 12, 2012

Record last verified: 2012-09

Locations